New Zealand markets closed

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
480.29+12.77 (+2.73%)
At close: 04:04PM EDT
480.29 +0.71 (+0.15%)
After hours: 04:08PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-3,627,535
-3,627,535
4,245,902
3,806,267
1,758,675
Depreciation & amortisation
137,300
137,300
133,800
138,100
134,200
Stock-based compensation
60,900
60,900
51,200
41,600
35,600
Change in working capital
-1,610,000
-1,610,000
1,142,200
1,087,600
555,900
Accounts receivable
-87,400
-87,400
-20,400
-15,000
1,600
Inventory
-158,800
-158,800
46,100
-52,100
24,200
Accounts payable
-94,200
-94,200
69,900
124,700
10,600
Other working capital
80,290
80,290
535,718
476,408
359,365
Other non-cash items
22,147
22,147
8,821
4,228
-1,003
Net cash provided by operating activities
194,447
194,447
656,521
575,328
457,897
Cash flows from investing activities
Investments in property, plant and equipment
-114,157
-114,157
-120,803
-98,920
-98,532
Acquisitions, net
-100,746
-100,746
-125,516
-96,655
-79,386
Purchases of investments
-2,060,238
-2,060,238
-1,305,067
-345,112
-450,836
Sales/maturities of investments
1,066,027
1,066,027
766,896
368,058
331,532
Other investing activities
-
-112,636
-658,922
36,405
-129,503
Net cash used for investing activities
-1,207,593
-1,207,593
-784,438
-60,250
-208,889
Cash flows from financing activities
Debt repayment
-510
-510
-3,020
-426,938
-643
Common stock repurchased
-215,679
-215,679
-49,998
-100,004
-28,000
Other financing activities
-14,015
-14,015
-23,043
-16,297
-11,059
Net cash used provided by (used for) financing activities
973,576
973,576
-55,429
-523,041
-22,758
Net change in cash
-36,589
-36,589
-195,982
4,464
228,487
Cash at beginning of period
471,133
471,133
667,115
662,651
434,164
Cash at end of period
434,544
434,544
471,133
667,115
662,651
Free cash flow
Operating cash flow
194,447
194,447
656,521
575,328
457,897
Capital expenditure
-114,157
-114,157
-120,803
-98,920
-98,532
Free cash flow
80,290
80,290
535,718
476,408
359,365